Had on the one and only Pat Stone today. Pat is a former FDA auditor, consultant and author of a fantastic book, Bubble Gum Badge, and FDA His Story”. In this interview Pat and I discuss CRA’s or monitors in the clinical research industry and how, this year in particular, they are busier than ever. Sounds good so far right? Well it turns out that these CRA’s are too busy and are jumping from CRO to CRO in order to alleviate their burdensome workloads and look for some type of stability for their work-life balance. As Pat and I discuss, this interesting phenomenon has caused delayed payments to sites in some cases as well as some adverse events not being properly reported from various studies. We then discuss how the FDA is beginning to look at this issue just now. Let me know what you think about this in the comments below.
Posts tagged payments
In today’s video, I interviewed Tudor Drancea, CFO of South Coast Clinical Trials. Tudor and I discuss the issue of payments and more specifically, how to ensure timely and efficient monthly payments from sponsors when a site is conducting clinical trials. Another interview I did a while back that is a must watch on the topic of budgeting and contracts is this chat with Ana Marquez, who is a contracts and budget expert in the world of clinical research. I hope this content can provide some value for you.
Todays video is all about the research clinics out there, and is a direct response to a question I received the other day. Basically, the research clinic hadn’t received a study payment for a particular study in several months, despite enrolling a good amount of study participants and having a contract with the Sponsor which stated monthly payments. In this video I suggest some strategies that I have tried myself, or have learned from my guest gurus on the program here. As always, I’m curious to learn of your experiences and how you were able to deal with these types of issues.
In today’s video, we discuss the trends we see in the clinical trials industry and how these trends may be affecting the research clinics out there. We get into the subjects of how to prepare for unforeseen events and properly invoice the pharma sponsors for these new procedures and unexpected study visits recently being observed in the industry. Let us know what you think in regards to these changes.
We’ve been getting asked tons of questions from people working within the clinical trials industry in regards to best practices when it comes to invoicing the study sponsor for payments and collecting on said payments. While this is a complicated issue, it actually doesnt have to be very difficult for a research site to figure out. It boils down to making sure that you actually do invoice regularly and making sure you do lots of following up on your invoicing. We certainly hope you all find this video helpful.